What Is the M367 Pill? Inside the Prescription Painkiller Found in Tiger Woods' Pocket After Florida Crash
When Florida law enforcement released updated investigative records on March 31, 2026, surrounding the circumstances of Tiger Woods' vehicular crash, search volumes for a specific pharmaceutical stamp spiked across the internet. Officers documented finding two loose white tablets inside the golf icon's pocket alongside admissions that he had been looking at his mobile device prior to losing control of the vehicle. According to an initial investigative report published by the TMZ Report, the recovered tablets were promptly cross-referenced by forensic investigators using standard pharmaceutical databases, identifying them as hydrocodone compounds.
For millions observing the news cycle, the discovery raised immediate questions about what the pill actually does, why it carries an M367 stamp, and how potent it is when operating heavy machinery. The white oblong tablet is one of the most widely prescribed pain medications in the United States, yet it remains one of the most heavily scrutinized compounds in clinical pharmacology.
📌 Key Takeaways:
- The Chemical Identity: A white pill imprinted with "M367" contains 10 mg of hydrocodone bitartrate and 325 mg of acetaminophen, manufactured by Mallinckrodt Pharmaceuticals.
- The Regulatory Tier: Classified by the DEA as a Schedule II controlled substance, indicating an accepted medical use accompanied by severe physical dependency risks.
- The Investigative Link: March 2026 police filings revealed two loose M367 tablets recovered from Tiger Woods during a traffic inquiry, spotlighting the line between post-surgical therapy and driver impairment.
Identifying the M367 Stamp: Chemical Makeup and Manufacturer
The code stamped into any prescription tablet functions as an unambiguous chemical serial number. An oblong white tablet bearing "M367" on one side and a single bisecting score line on the reverse contains precisely 10 mg of hydrocodone bitartrate paired with 325 mg of acetaminophen. The "M" inside a box or stylized square denotes Mallinckrodt Pharmaceuticals, a major supplier of generic analgesics across North America.
The combination belongs to a class of combination drugs formerly sold under brand names such as Norco 10/325 and Vicodin HP. The hydrocodone component acts directly on mu-opioid receptors within the central nervous system to intercept pain signaling between peripheral nerves and the brain. Acetaminophen works as a non-opioid synergistic agent, inhibiting prostaglandin synthesis in spinal pathways to enhance pain relief without requiring a higher, more hazardous narcotic dose.
Prior to 2014, retail pharmacies dispensed hydrocodone combinations with up to 500 mg or 650 mg of acetaminophen per dose. The U.S. Food and Drug Administration eliminated those elevated ratios after clinical data showed that acetaminophen toxicity accounted for roughly 50% of all acute liver failure cases nationwide. Modern formulations like the M367 tablet cap the non-opioid base at 325 mg to preserve hepatic safety during prolonged treatment plans.
How Two Loose Pills Entered the Tiger Woods Investigation
The March 31, 2026 investigative disclosures placed the M367 pill back at the center of sports headlines. Traffic officers responding to the scene noted that the 15-time major champion appeared disoriented and admitted to glancing down at his phone before the impact occurred. A search conducted during the initial DUI evaluation produced two loose tablets from his clothing pocket, which laboratory technicians later logged as generic hydrocodone/acetaminophen 10/325 mg.
Woods has sustained extensive orthopedic trauma throughout his professional career, undergoing multiple microdiscectomies, spinal fusions, and reconstructive lower-leg surgeries following his catastrophic 2021 rollover collision in Southern California. Managing chronic spinal nerve pain often leads athletes to valid narcotic prescriptions. However, forensic toxicology teams routinely focus on systemic accumulation rather than prescription validity alone.
Carrying loose pills outside their original dispensing container presents both evidentiary and regulatory challenges. Florida statutes, alongside broader state transport laws, require controlled medications to remain in labeled pharmacy packaging displaying the patient's name, prescribing physician, and dispensing date. When recovered loose, law enforcement must treat the substances as unverified narcotics until laboratory pill identification verifies the chemical profile.
Hydrocodone Formulations and Strength Comparisons
Mallinckrodt manufactures several tiered variations of hydrocodone/acetaminophen, each distinguished by a distinct numerical stamp indicating its opioid strength. Knowing the difference between these formulations is essential for assessing therapeutic dosing versus dangerous toxicity.
| Imprint Code | Active Ingredients | Brand Equivalent | Standard Therapeutic Target |
|---|---|---|---|
| M365 | Hydrocodone 5 mg / Acetaminophen 325 mg | Norco 5/325 | Mild-to-moderate outpatient acute pain |
| M366 | Hydrocodone 7.5 mg / Acetaminophen 325 mg | Norco 7.5/325 | Moderate postoperative rehabilitation |
| M367 | Hydrocodone 10 mg / Acetaminophen 325 mg | Norco 10/325 | Severe chronic pain; major orthopedic recovery |
| IP 109 | Hydrocodone 5 mg / Acetaminophen 325 mg | Norco generic (Amneal) | Dental extractions; minor soft tissue injuries |
The M367 imprint marks the highest hydrocodone threshold authorized within the Norco dosage framework. Taking two M367 tablets at once delivers 20 mg of pure hydrocodone alongside 650 mg of acetaminophen. For an opioid-naive individual, 20 mg can cause marked dizziness, slowed breathing, and significant mental clouding within forty minutes of oral ingestion.
Driving Impairment, Reflex Lag, and Schedule II Hazards
Operating a vehicle under the influence of hydrocodone carries distinct physiological markers that field sobriety tests quickly uncover. As a central nervous system depressant, the opioid component degrades depth perception, constricts pupils, and prolongs motor response latency by hundreds of milliseconds. When an emergency stop demands instant reflex action, that chemical delay translates to dozens of extra feet in vehicle stopping distance.
The Drug Enforcement Administration reclassified hydrocodone combination products from Schedule III to Schedule II in October 2014. The federal agency enacted that shift after data proved that hydrocodone-acetaminophen pills caused more emergency room visits and diversion cases than nearly any other pharmaceutical class. Under Schedule II regulations, patients cannot receive automatic prescription refills; each new order requires a dedicated electronic prescription from a licensed physician.
The risks intensify when patients combine hydrocodone with fatigue, muscle relaxants, or sleep aids like Ambien. Sedation compounds exponentially rather than linearly. While a patient may feel capable of driving down a familiar highway, subtle deficits in spatial tracking and peripheral awareness can cause unexpected drifting or sudden lane excursions.
Counterfeit Pressings, Street Risks, and Pill Verification
The widespread familiarity of the M367 imprint has made it a frequent target for illicit pill counterfeiters. Public health advisories from the DEA and forensic state laboratories consistently highlight that millions of pressed counterfeit tablets entering the illicit market mimic authentic pharmaceutical stamps, including Mallinckrodt's M367 imprint.
Underground laboratories use industrial pill presses to replicate the exact dimensions, white color, and scoring lines of authentic M367 tablets. Instead of laboratory-grade hydrocodone and acetaminophen, these counterfeit copies often contain lethal doses of illicit fentanyl mixed with binding powders. A single pressed fake can contain anywhere from 1 mg to over 5 mg of fentanyl, easily exceeding lethal toxicity levels for any user lacking medical oversight.
Legitimate M367 pills feature crisp, uniform debossing, hard tablet edges that do not crumble when handled, and consistent chalk-white coloration. Any tablet obtained outside a state-licensed retail or hospital pharmacy carries high contamination risks. Utilizing professional pill identifier tools and retaining medicines in their original prescription bottles remains the only dependable way to guarantee chemical purity and stay clear of dangerous legal scrutiny.
Frequently Asked Questions (FAQ)
Q1: Can taking a legally prescribed M367 pill lead to a DUI charge?
A1: Yes. Driving under the influence statutes apply to any intoxicating substance, regardless of whether you hold a valid doctor's prescription. If a prescription painkiller impairs your normal faculties, motor reflexes, or mental clarity behind the wheel, officers can arrest and prosecute you for impaired driving.
Q2: How does the M367 tablet differ from standard Percocet?
A2: While both are combination painkillers containing 325 mg of acetaminophen, their primary opioid is different. M367 contains 10 mg of hydrocodone bitartrate, whereas Percocet typically combines acetaminophen with oxycodone hydrochloride. Oxycodone is roughly 1.5 times more potent milligram-for-milligram than hydrocodone.
Q3: How long does hydrocodone from an M367 tablet stay in your body?
A3: The analgesic pain relief generally lasts 4 to 6 hours, with a biological half-life of roughly 3.8 hours in healthy adults. However, urine toxicology panels detect hydrocodone metabolites for 2 to 4 days after ingestion, and hair follicle screenings can trace exposure for up to 90 days.
The Clinical Reality Behind Prescription Pain Management
Prescription analgesics like the M367 tablet highlight the ongoing challenge facing contemporary pain medicine. For people coping with spinal trauma, degenerative disc conditions, or intensive reconstructive procedures, hydrocodone combination therapy can restore basic mobility when physical therapy and non-steroidal anti-inflammatory drugs fall short. The relief it provides, however, comes tied to narrow therapeutic windows and strict behavioral precautions.
As the forensic and legal facts in Florida make clear, carrying unbottled Schedule II narcotics blurs the line between legitimate pain therapy and avoidable impairment. Understanding the precise chemical identity, dosage thresholds, and physiological impacts of the M367 imprint gives patients, caregivers, and observers the clarity needed to separate clinical necessity from public risk.